Login
Toggle navigation
Videos
Categories
Trending
Controversial Role of LLMs in Medical Manuscript Writing - Dr. Pablo Moreno Franco
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Controversial Role of LLMs in Medical Manuscript Writing
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Promoting Mercury-Free Gold Recovery Technologies in Peru
00:10:00
Livingbridge Announces Strategic Partnership with Gresham House | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Jamie Montgomery: From High School Entrepreneur to March Capital Co-Founder
00:10:00
Seeking viewer input on future visions, as discussed by a construction industry leader | Keiichi Yoshii, CEO , Daiwa house industry co.
00:10:00
Goldman Sachs' Strategic Roadmap: Enhancing Growth and Managing Risk | Harvey Schwartz, Co-president , Goldman Sachs Group Inc.
00:10:00
Josh Friedman: Mastermind of Credit Investing and Co-Founder of Canyon Partners
00:10:00
Dan Smith Discusses Global Base Metals Market Trends and the Impact of China's Economic Dynamics at the London Metal Exchange
00:10:00
Early-stage VC fund investing in tech that improves|Maria (Toler) Velissaris,Founding and Managing Partner,SteelSky Ventures
00:10:00
Cutting Through Financial Confusion with Clear, Flat-Fee Advising
00:10:00
Discovering the Depths: A Journey Through Oceanographic Research |William H. Rogers Jr, Chairman , Truist Financial.
00:10:00
Emphasizing Patient Centricity and Innovation in Clinical Trials
00:10:00
Innovative PVD Coating Solutions for Hydrogen Applications | Stefan Dreger, President EMEA Hydrogen Solutions Impact Coatings